In this 15-minute lecture from Rebellion in EM 2021, George Willis, MD discusses acute ischemic stroke and the evidence base for and against thrombolysis.
In this 9 minute video from day 2 of Rebellion in EM 2021, I go over the evidence for advanced imaging use in acute ischemic stroke of unknown time of onset to help guide treatment with intravenous alteplase.
Background: The mainstays for management of stroke include admission to a stroke center and management of modifiable risk factors.1,2,3 It is estimated that most strokes are ischemic (87%),4 and atrial fibrillation and/or flutter are thought to be responsible for approximately ...
Background: Acute basilary artery occlusion has a high morbidity and mortality. Treatment strategies for acute basilar artery occlusion are rather sparse. Endovascular research over the last 5 years (REBEL EM Post) adds little to the conversation of these strokes as ...
Background: Alteplase has been the accepted thrombolytic for acute ischemic stroke (AIS) for 25 years. However, recent data has emerged regarding tenectaplase as an alternative. Tenecteplase is a modified form of alteplase, with a lower cost and more favorable pharmacokinetic ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
